NCT01245322View on ClinicalTrials.gov

Treatment of Bacterial Vaginosis Combined With Human Lactobacilli

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Bacterial Vaginosis
Interventions
DRUG

lactobacilli

women were given a seven days course of daily 2% vaginal clindamycin cream (Dalacin vaginal cream 2%, Pfizer Norway Ltd) together with oral clindamycin 300 mg BID for 7 days (Dalacin 300 mg, Pfizer Norway Ltd). Oral clindamycin treatment was also given to the patient's sexual partner.

Trial Locations (1)

3002

Gynekologklinikken, Drammen

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

lead

Skaraborg Hospital

OTHER_GOV

NCT01245322 - Treatment of Bacterial Vaginosis Combined With Human Lactobacilli | Biotech Hunter | Biotech Hunter